dapsone has been researched along with Opportunistic Infections in 17 studies
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have treated 113 patients with zidovudine since its licensure, 80 with acquired immunodeficiency syndrome and 33 with acquired immunodeficiency syndrome-related complex." | 7.67 | Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex. ( Gor, D; Helbert, M; Janes, K; Jeffries, DJ; Kocsis, AE; Mitchell, D; Peddle, B; Pinching, AJ; Robinson, D; Stoneham, C, 1989) |
| "The relative risks of non-specific upper respiratory tract infections were studied in two well matched groups of military recruits to see whether dapsone-pyrimethamine (Maloprim) given as antimalarial prophylaxis was associated with immunosuppression." | 7.67 | Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria. ( Lau, EY; Lee, PS, 1988) |
| "We have treated 113 patients with zidovudine since its licensure, 80 with acquired immunodeficiency syndrome and 33 with acquired immunodeficiency syndrome-related complex." | 3.67 | Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex. ( Gor, D; Helbert, M; Janes, K; Jeffries, DJ; Kocsis, AE; Mitchell, D; Peddle, B; Pinching, AJ; Robinson, D; Stoneham, C, 1989) |
| "The relative risks of non-specific upper respiratory tract infections were studied in two well matched groups of military recruits to see whether dapsone-pyrimethamine (Maloprim) given as antimalarial prophylaxis was associated with immunosuppression." | 3.67 | Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria. ( Lau, EY; Lee, PS, 1988) |
| "Pneumocystis carinii pneumonia is a life-threatening complication of diseases and therapies associated with immunosuppression." | 2.38 | Pneumocystis carinii: a deadly opportunist. ( Tsou, E; Zackrison, LH, 1991) |
| " In 2005, the University of Kentucky (UK) Transplant Center implemented a novel dosing regimen of weekly dapsone as an alternative for patients with contraindications or intolerability to trimethoprim-sulfamethoxazole (TMP-SMZ), which remains the drug of choice." | 1.42 | Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation. ( Au, T; Clifford, TM; Evans, RA; Fugit, AM; Tang, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 10 (58.82) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Queener, SF | 1 |
| Malasingam, R | 1 |
| Ranganathan, D | 1 |
| Jeyaseelan, L | 1 |
| Ramanathan, K | 1 |
| Jacks, M | 1 |
| Owens, J | 1 |
| John, GT | 1 |
| Evans, RA | 1 |
| Clifford, TM | 1 |
| Tang, S | 1 |
| Au, T | 1 |
| Fugit, AM | 1 |
| Rizk, N | 1 |
| Kamiya-Matsuoka, C | 1 |
| Tremont-Lukats, IW | 1 |
| Diri, R | 1 |
| Anwer, F | 1 |
| Yeager, A | 1 |
| Krishnadasan, R | 1 |
| McBride, A | 1 |
| Palamanda, JR | 1 |
| Hickman, D | 1 |
| Ward, A | 1 |
| Sim, E | 1 |
| Romkes-Sparks, M | 1 |
| Unadkat, JD | 2 |
| Blum, RN | 1 |
| Miller, LA | 1 |
| Gaggini, LC | 1 |
| Cohn, DL | 1 |
| Mohle-Boetani, J | 1 |
| Akula, SK | 1 |
| Holodniy, M | 1 |
| Katzenstein, D | 1 |
| Garcia, G | 1 |
| Hardy, WD | 2 |
| Slattery, JT | 1 |
| Gallant, JE | 1 |
| Hoehn-Saric, E | 1 |
| Smith, MD | 1 |
| Zackrison, LH | 1 |
| Tsou, E | 1 |
| Pinching, AJ | 1 |
| Helbert, M | 1 |
| Peddle, B | 1 |
| Robinson, D | 1 |
| Janes, K | 1 |
| Gor, D | 1 |
| Jeffries, DJ | 1 |
| Stoneham, C | 1 |
| Mitchell, D | 1 |
| Kocsis, AE | 1 |
| Lee, PS | 1 |
| Lau, EY | 1 |
7 reviews available for dapsone and Opportunistic Infections
| Article | Year |
|---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infectio | 1995 |
The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dapsone; Drug Hypersensitivity; Humans; Male; Opportunist | 1992 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
Pneumocystis carinii: a deadly opportunist.
Topics: Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; Clinical Protocols; Dapsone; Decision Trees; Dia | 1991 |
[Pneumocystis carinii pneumonia in HIV infections. Committee of the 1st Consensus Conference of anti-infectious therapy organized in May 1990 in Paris by the Société de Pathologie Infectieuse de Langue Française].
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Clinical Protocols; Dapsone; France; HIV Infections; H | 1990 |
[Consensus conference: pneumocystosis in HIV infections. 1st consensus conference in anti-infection therapeutics organized by "la Société de Pathologie Infectieuse de langue française", May 11, 1990].
Topics: Adrenal Cortex Hormones; Dapsone; France; HIV Infections; Humans; Opportunistic Infections; Pentamid | 1990 |
Prophylaxis of AIDS-related opportunistic infections (OIs).
Topics: Acquired Immunodeficiency Syndrome; Cryptococcosis; Cytomegalovirus Infections; Dapsone; Drug Combin | 1989 |
2 trials available for dapsone and Opportunistic Infections
| Article | Year |
|---|---|
Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia.
Topics: Adult; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infec | 1992 |
Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Animals; Cryptococcosis; Cytomegalovirus Infections; D | 1991 |
9 other studies available for dapsone and Opportunistic Infections
| Article | Year |
|---|---|
An audit of dapsone-associated methaemoglobinaemia in renal transplant recipients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dapsone; Female; Humans; Kidney Transplantati | 2014 |
Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
Topics: Anti-Infective Agents; Cohort Studies; Dapsone; Humans; Immunosuppressive Agents; Kidney Transplanta | 2015 |
Lower Extremity Edema, Anxiety, and Cyanosis During Chemoradiation Therapy for Glioblastoma.
Topics: Anti-Infective Agents; Anxiety; Brain Neoplasms; Chemoradiotherapy; Cyanosis; Dapsone; Edema; Female | 2016 |
Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Atovaquone; Child; Child, Preschool; Dapsone; Fem | 2016 |
Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
Topics: Acetylation; Adult; Anti-Bacterial Agents; Arylamine N-Acetyltransferase; Base Sequence; Cloning, Mo | 1995 |
Adverse reactions to co-trimoxazole in HIV infection.
Topics: Cytochrome P-450 Enzyme System; Dapsone; HIV Seropositivity; Humans; Opportunistic Infections; Pneum | 1991 |
Respiratory insufficiency from dapsone-induced methemoglobinemia.
Topics: Adult; Dapsone; HIV Infections; Humans; Male; Methemoglobinemia; Opportunistic Infections; Pneumonia | 1991 |
Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Complex; Bone Marrow; Brain Diseases; Da | 1989 |
Risk of acute non-specific upper respiratory tract infections in healthy men taking dapsone-pyrimethamine for prophylaxis against malaria.
Topics: Acute Disease; Adolescent; Antimalarials; Dapsone; Drug Combinations; Humans; Immunosuppression Ther | 1988 |